Chronic Hepatitis News

BOSTON — In this exclusive video from The Liver Meeting 2019, Tarek Hassanein, MD, FAASLD, professor of medicine at UC San Diego Health and medical director of Southern California GI and Liver Centers, discusses results of a phase 2a study, which demonstrated that DUR-928 was well-tolerated and effective in patients with acute alcoholic hepatitis.

BOSTON — In this exclusive video from The Liver Meeting 2019, Douglas T. Dieterich, MD, director of the Institute for Liver Medicine at the Icahn School of Medicine at Mount Sinai, discusses results of a study that showed that loss of surface antigen among individuals coinfected with HIV and chronic hepatitis B virus infection was similar to rates previously reported in patients with HBV monoinfection.

BOSTON — In this exclusive video from The Liver Meeting 2019, Robert S. Brown Jr., MD, MPH, of Weill Cornell Medical College, discusses the results of the EXPEDITION-8 trial, which demonstrated that treatment with Mavyret over 8 weeks was effective and had a favorable safety profile in patients with treatment-naive chronic hepatitis C virus genotypes 1-6 and compensated cirrhosis.

Albumin levels and liver stiffness measurements taken during direct-acting antiviral therapy follow-up can stratify liver cancer risk among patients with hepatitis C and compensated advanced chronic liver disease, according to study results.

Researchers discovered potential for a simplified monitoring schedule compared with standard monitoring among certain patients treated direct-acting antivirals for chronic hepatitis C, according to data published in Journal of Hepatology.

NEW ORLEANS — Quality improvement projects focused on education and multidisciplinary cooperation have been successful at improving hepatitis B vaccination rates among neonates, according to a pair of studies presented at the AAP National Conference & Exhibition.

SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Stephen A. Harrison, MD, medical director of Pinnacle Clinical Research in San Antonio, provides an overview of the topics discussed at the meeting ranging from nonalcoholic steatohepatitis to hepatitis B to liver cancer.

SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Robert S. Brown, MD, from the Weill Cornell Medical Center, examines “who to treat” among patients with hepatitis B based on a panel discussion from the meeting.

SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Robert Gish, MD, an adjunct professor at the University of Nevada Reno School of Medicine, provides an overview of a presentation on hepatitis B that focused on which patients benefit the most from treatment.

SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services important for all practitioners involved in the care of patients with liver disease.